Thailand Hub of Talents in Cancer Immunotherapy (TTCI) Inauguration Ceremony and Memorandum of Understanding (MOU) Signing
Bangkok, August 10, 2023 – Associate Prof. Chanchai Sittipunt, Dean of the Faculty of Medicine, Chulalongkorn University, along with Prof. Apichat Asavamongkolkul, Dean of the Faculty of Medicine Siriraj Hospital, Mahidol University, Prof. Roengsak Leetanaporn, Dean of the Faculty of Medicine, Prince of Songkla University, and Prof. Apichat Jiravuttipong, Dean of the Faculty of Medicine, Khon Kaen University, jointly unveiled the Thailand Hub of Talents in Cancer Immunotherapy (TTCI). This center, supported by the National Research Council of Thailand (NRCT), aims to advance high-level research and cultivate leading researchers who will contribute significantly to the nation’s knowledge landscape. It involves personnel exchanges with international networks to facilitate technology and knowledge transfer, fostering high-value economic and societal innovations.
This event also marked the signing of a Memorandum of Understanding (MOU) between the Deans of four prominent medical institutions, solidifying their collaboration in developing immune-based cancer treatments, particularly cell-based therapies. The partnership will focus on creating standardized mechanisms for effective treatments within hospitals. It will harmonize efforts with related organizations, including the Medical Council of Thailand, the Food and Drug Administration, and the Department of Medical Sciences.
The establishment of the TTCI not only brings together national experts but also serves as a crucial step towards propelling research forward by leveraging the expertise of each institution. The center will serve as a foundation for global collaborations in cancer immunotherapy research and innovation.
Prof. Dr. Nattiya Hirankarn, Director of the Thailand Hub of Talents in Cancer Immunotherapy; Prof. Dr. Pa-Thai Yenchitsomanus, Director of the Siriraj Center of Research Excellence for Cancer Immunotherapy; Dr. Koramit Suppipat, Director of Cellular Immunotherapy Research Unit, Chulalongkorn University and Medical Director of Cell and Gene Therapy Manufacturing Center, King Chulalongkorn Memorial Hospital; Assoc. Prof. Jakrawadee Julamanee, Vice President for Research and Development and Head of the Stem Cell Transplantation and Cell-Based Therapy Unit, Faculty of Medicine, Prince of Songkla University, and Assist. Prof. Jutarop Phetcharaburanin, Assistant Dean for Research and Public Relations and Chairperson of KKU Phenome Centre, Faculty of Medicine, Khon Kaen University, jointly expressed their enthusiasm for the ongoing collaborative efforts, emphasizing that the TTCI has already started compiling researcher profiles, expertise, research resources, and achievements related to cancer immunotherapy on its website: https://www.ttci-th.org/. The center plans to organize academic conferences, workshops, and training sessions, with updates available on social media platforms such as Facebook: Thailand Hub of Talents in Cancer Immunotherapy and Twitter: Thailand Hub of Talents in Cancer Immunotherapy.
Students, researchers, and individuals interested in participating in training or research activities are invited to contact info.ttci.th@gmail.com for more information.
Back to MDCU News
About Post Author
